GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (NSE:GLAXO) » Definitions » ROE % Adjusted to Book Value

GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) ROE % Adjusted to Book Value : 2.17% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals ROE % Adjusted to Book Value?

GlaxoSmithKline Pharmaceuticals's ROE % for the quarter that ended in Sep. 2024 was 60.38%. GlaxoSmithKline Pharmaceuticals's PB Ratio for the quarter that ended in Sep. 2024 was 27.86. GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 2.17%.


GlaxoSmithKline Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals ROE % Adjusted to Book Value Chart

GlaxoSmithKline Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 1.31 7.72 2.15 1.81

GlaxoSmithKline Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 - 2.36 - 2.17

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value falls into.



GlaxoSmithKline Pharmaceuticals ROE % Adjusted to Book Value Calculation

GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=33.53% / 18.55
=1.81%

GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=60.38% / 27.86
=2.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.

GlaxoSmithKline Pharmaceuticals Headlines

No Headlines